Cytokinetics, Incorporated · NASDAQ:CYTK
Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)
Traded Jul 27, 2026 · Filed Jul 27, 2026
On Jul 27, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at US$80.87 for US$607K under a trading plan, leaving 377,820 shares. Filed Jul 27, 2026 (Form 4).
- Sold
- 7,500 shares
- Price
- US$80.87
- Value
- US$607K
- Holding after
- 377,820 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Common Stock | Option exercise | 7,500 | US$10.60 | 385,320 | Direct |
| Jul 27, 2026 | Common Stock | Sale | 7,500 | US$80.87 | 377,820 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Blum Robert I
- Cytokinetics, Incorporated shareholders
- Form 4 · Blum Robert I · Oct 13, 2026
- Form 4 · Blum Robert I · Sep 28, 2026
- Form 4 · Blum Robert I · Sep 15, 2026
- Form 4 · Blum Robert I · Aug 31, 2026
- Form 4 · Blum Robert I · Aug 10, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026